LB Pharmaceuticals
(Incorporated in Delaware) We are a clinical-stage biopharmaceutical company developing novel therapies to treat schizophrenia, bipolar depression, and other neuropsychiatric diseases. We are building a pipeline that leverages the broad therapeutic potential of our lead product candidate, LB-102, which we believe has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in […]
August 25, 2025 Read More